(1)
Heart and Vascular Institute, Penn State Hershey Medical Center, 500 University Drive, MC H053, Hershey, PA 17033, USA
Keywords
VasculitisAneurysmsCystic adventitial diseaseBuerger’s diseaseRaynaud’s syndromeEmbolismRadiationArterial Causes of Lower Extremity Ischemia
Atherosclerosis is the most common cause of pain in the lower extremities. It can present as pain in the affected muscles upon exercise in initial stages of the disease or as rest pain and tissue loss in cases with advanced disease. Atherosclerotic plaques can be defined as a combination of changes in the intima of arteries including accumulation of lipids, complex carbohydrates, blood and blood products, fibrous tissue, and calcium deposits. Advanced plaques can invade the media and produce significant changes in the arterial wall including bulging or enlarged arteries. Advanced lesions are characterized by round cell infiltration, medial changes, and neovascularization.
The first stage of atherosclerosis is the “fatty streak” with minimally raised yellow lesions, containing lipids deposited intracellularly in macrophages and smooth muscle cells . This can then progress to form “foam cells” with LDL infiltration of macrophages that characterizes more advanced lesions. Oxidation of LDL causes further attraction of monocytes, which in turn become macrophages that produce cytokines that can initiate an inflammatory cascade. Lesions can then progress to fibrous plaques which are composed of large numbers of smooth muscle cells and connective tissue that forms a fibrous cap over an inner yellow (atheromatous) core. Fibrous plaques likely evolve from fatty streaks, with gelatinous plaques or injured arterial areas less commonly leading to plaque formation. Plaques can protrude into the arterial lumen causing compensatory remodeling of the arterial wall with dilatation. Plaque formation can also cause severe inflammatory reaction to promote inflammation, fibrosis, and lymphocytic infiltration. Neovascularization of the adventitia characterizes fibrofatty and fibrous plaque lesions. Fibrous plaques can further become complicated by calcification, ulceration, intraplaque hemorrhage, or necrosis. Later developments can cause the clinical complications of stroke, gangrene, and myocardial infarction. Alternatively, aneurysmal degeneration can develop secondary to severe atherosclerosis and may represent mechanical arterial response to the disease process.
There are several theories of the pathogenesis of atherosclerotic lesions. The lipid hypothesis proposed by Virchow states that atherosclerotic lesions are reactive responses to lipid infiltration. There has been an important epidemiologic link between hyperlipidemia and atherosclerosis, but this is not the only pathogenic factor. The thrombogenic hypothesis proposed in the mid-nineteenth century states that fibrinous substances are deposited on the arterial intimal surface as a result of abnormal hemostatic elements in the blood and undergo changes that result in atheromatous masses. Hemodynamic effects are also felt to play a role in the development of atherosclerotic disease. Pulsations associated with the cardiac cycle at branch points, unions, curvatures, and fusiform dilatations are responsible for fatigue failure, and atherosclerosis develops as a function of age. There is also a significant response-to-injury hypothesis in which the endothelium is injured either by migration of monocytes and macrophages in the setting of hypercholesterolemia or by outside insults including diabetes, cigarette smoking, or hypertension. Arterial trauma secondary to clamping or balloon injury can also produce stenoses either by myointimal hyperplasia or atheroma formation.
Atherosclerotic disease is a primary contributing etiology in the majority of cases of CLI. There is significant discussion of atherosclerotic disease throughout this textbook, and as such, this chapter will only highlight atherosclerotic lesions. Of patients with atherosclerotic lower extremity PAD, <5 % (1–3.3 %) will progress to CLI or amputation [1]. The incidence of new CLI is estimated at 220 new cases/year/million people [1]. Furthermore, it is important to recognize that above the ankle, most ulcerations are venous in etiology, whereas the majority of foot ulcers are arterial in nature [1]. It is important to note that many ulcers have multiple etiologies and each should be systematically addressed. Regardless of the arterial etiology (atherosclerotic or non-atherosclerotic), when the blood flow is insufficient to maintain tissue integrity, then an ulcer will develop; interestingly, cardiac dysfunction (low output states from congestive heart failure or valvular heart disease) may contribute to insufficient nutrient supply [1]. Typically, for CLI to develop, long-segment or multilevel disease is required.
While it is important to diagnose and appropriately classify the stage of peripheral arterial disease, the clinician must recognize the fact that there are multiple causes of lower extremity ischemia, which might not be related to atherosclerosis Table 11.1 [1]. Knowledge about non-atherosclerotic etiologies of lower extremity ischemia is crucial in making an accurate diagnosis and implementing appropriate treatment. The following text describes non-atherosclerotic conditions, associated with lower extremity ischemia.
Table 11.1
Non-atherosclerotic causes of peripheral vascular disease
Vasculitis |
Takayasu’s arteritis |
Giant cell arteritis |
Medium vessel (polyarteritis nodosa, Kawasaki’s disease) |
Small vessel (Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome) |
Anatomic causes |
Femoral and popliteal aneurysms |
External iliac artery endofibrosis |
Cystic adventitial disease |
Popliteal artery entrapment |
Congenital causes |
Persistent sciatic artery |
Mid-aortic syndrome |
Ehlers-Danlos syndrome |
Pseudoxanthoma elasticum |
Immunologic |
Thromboangiitis obliterans (Buerger’s disease) |
Raynaud’s syndrome |
Calciphylaxis |
Drug related |
Warfarin-induced skin necrosis |
Heparin-induced skin necrosis |
Ergot derivatives |
Others |
Atheroembolic episodes |
Radiation |
Brown recluse spider bite |
Neurogenic claudication |
Vasculitis
Systemic vasculitis, involving inflammation of the blood vessels, often is associated with necrosis and occlusive changes with diverse clinical manifestations. The most useful classification is based on the arterial size of affected arteries—large vessel vasculitides include giant cell (temporal) arteritis and Takayasu’s arteritis; medium vessel vasculitides include polyarteritis nodosa and Kawasaki’s disease; small vessel vasculitides include Wegener’s granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome. The cause and pathogenesis of most vasculitides are complex and are currently incompletely understood. An immune-mediated injury is one of the basic mechanisms proposed that results in deposition of immune complexes in a vessel wall with complement activation and injury, deposition of antigen in a vessel wall, or a delayed hypersensitivity reaction. They are associated with cellular immunoreaction involving production of cytokines that results in neutrophilic, eosinophilic, monocytic, and lymphocytic interactions at the inflammatory site. The presentation of vasculitis is usually associated with subjective symptoms such as fever, malaise, myalgias, and arthralgias [2]. Patients also tend to have elevated inflammatory markers (erythrocyte sedimentation rate and C-reactive protein) in the acute phase, and chronically they can develop long segments of smooth narrowing or aneurysmal dilatation.
Treatment during acute stage involves administering anti-inflammatory agents with corticosteroids being the mainstay of therapy. Other immunosuppressant agents (methotrexate, azathioprine, and cyclophosphamide) have been described as well for refractory or recurrent symptoms. During the later fibrotic stage of the disease, patients may develop symptomatic ischemia with claudication, rest pain, or aneurysmal degeneration. Patients with symptomatic disease or aneurysm formation can be treated with general endovascular or open surgical procedures, if appropriate indications exist .
Takayasu’s Arteritis
Takayasu’s arteritis (TA ) is a large vessel vasculitis that frequently affects the aorta and its major branches, in addition to the pulmonary artery. It typically affects young women of Asian or Latin descent, with a median age of onset of 25–41 years. There has been a reported prevalence of 0.8 per million in the United Kingdom database, compared with 3.3 per million in Japan. There are two recognized stages of the disease with the first characterized by fever, myalgias, and anorexia in two thirds of patients. In the second stage, the symptoms are followed by multiple arterial occlusive symptoms dependent on disease location. The areas of disease involvement have been characterized as types II, III, IV, and I. Type I TA is limited to the aortic arch and arch vessels and occurs in 8.4 % of patients. Type II TA involves the descending thoracic and abdominal aorta and accounts for 11.2 % of patients. Type III TA involves the arch vessels and the abdominal aorta and its branches and accounts for 65.4 % of cases. Type IV TA is primary pulmonary artery involvement, with or without other vessels, and accounts for 15 % of patients.
Diagnosis is made based on history and physical exam, in addition to imaging modalities. Most lesions are stenotic, although localized aneurysms have been reported. On physical exam, diminished peripheral pulses may be seen in addition to hypertension (due to aortic coarctation or renal artery stenosis). Neurologic symptoms can result from hypertension or central nervous system ischemia associated with cerebrovascular stenosis. Coronary artery involvement in TA is rare, and any cardiac pathology associated with the disease is usually secondary to systemic and/or pulmonary hypertension. Arteriography has traditionally been the diagnostic modality of choice. Duplex ultrasonography, CT scan, and MRI have also recently emerged as alternatives to provide information affected vessels .
Medical therapy is the treatment of choice for the disease in the acute phase. Corticosteroids are the cornerstone of medical therapy, with cytotoxic agents (methotrexate), immunosuppressants (azathioprine, cyclosporine), and antitumor necrosis factor monoclonal antibody (infliximab) being used occasionally. Surgical intervention is generally reserved to treat symptomatic or aneurysmal lesions as a result of chronic Takayasu’s arteritis. Surgical intervention is not recommended in the acute phase of the disease and is more likely to be successful in the quiescent state. Restenosis rates in the presence of active disease are as high as 45 %, compared with 12 % with the disease in remission. Surgical management may require bypass graft construction to disease-free arterial segments with continuation of corticosteroid therapy. Long-term survival rates are excellent with rates up to 75 % at 20 years.
Femoral and Popliteal Artery Aneurysms
Peripheral arterial aneurysms of the lower extremity are the second most common cause of arterial aneurysm after abdominal aortic aneurysm (AAA). Unlike AAA, however, the natural history of extremity arterial aneurysms is thromboembolism and not expansion and rupture. True aneurysms of the lower extremities are secondary to atherosclerosis and are degenerative in nature, unlike false aneurysms (pseudoaneurysms), which are often the result of access site complications from endovascular procedures. Both femoral and popliteal artery aneurysms are strongly associated with aneurysms of the contralateral extremity and those of the abdominal aorta, with as many as 50 % having concurrent AAA. The diagnosis of lower extremity aneurysm mandates routine imaging evaluation to rule out disease in the contralateral extremity and the abdominal aorta.
Femoral Aneurysms
True degenerative aneurysms (including all three layers of the arterial wall) must be distinguished from false aneurysms or pseudoaneurysms . True degenerative aneurysms of the common femoral artery are relatively rare, with aneurysms of the superficial and deep femoral arteries being even less common. Femoral aneurysms are frequently asymptomatic and can be discovered incidentally as pulsatile masses or may present with localized pain or distal ischemia secondary to thromboembolic events. It is rare that a femoral aneurysm would rupture or bleed spontaneously. Once discovered, they should be evaluated with duplex ultrasound or contrast-enhanced CT scan with additional objective to evaluate for other concurrent aneurysms and the anatomic extent of the aneurysm. Contrast angiography and MRA can be used as adjunctive diagnostic tests to further provide information regarding the patency of outflow vessels if concern for thromboembolism exists.
All symptomatic femoral aneurysms regardless of etiology should be repaired. True aneurysms larger than 2.5 cm at presentation should be considered for repair; aneurysms less than 2.5 cm typically have a benign natural history and can be followed serially with duplex ultrasound. Open surgical repair for aneurysms isolated to the common femoral artery remains the gold standard of management with excellent early- and long-term results. Endovascular options are generally not recommended due to the flexion crease at the groin, which can subject endovascular prostheses to potential kinking, migration, and stent fatigue. Reconstruction depends on the extent of the aneurysm, the patency of the femoropopliteal segment, and the aneurysm patency. Type I femoral aneurysms (limited to the proximal common femoral artery) are often repaired with an interposition graft. Aneurysms that involve the origin of the deep femoral artery (type II) will require more complex reconstruction that involves revascularization of both the deep and superficial femoral arteries. Prosthetic grafts with 8–10 mm polyester or expanded polytetrafluoroethylene (ePTFE ) can be used for most cases, although if concern for infected or mycotic aneurysms exists reversed saphenous vein graft would be the conduit of choice. Exposure can be achieved through a vertical groin incision to allow for proximal control of the common femoral artery as well as control of the superficial femoral artery and deep femoral artery branches. For aneurysms of the deeper branches of the deep femoral artery, ligation may be used or endovascular techniques with coil embolization can be utilized. Treatment of aneurysms of the superficial femoral artery depends on location with open surgical techniques preferred with interposition grafting of the proximal superficial femoral artery. Alternatively, bypass in conjunction with proximal and distal ligation of the aneurysmal segment is another viable option. Endovascular stent grafts have also been reported in the mid to distal superficial femoral artery.
Individual institution results have shown a 5-year patency rate of up to 85 % for open surgical repair of common femoral artery aneurysms, with choice of conduit not affecting results. Deep and superficial femoral artery aneurysms are rarer and do not have long-term results reported. Endovascular repairs have been recently reported with satisfactory short-term patency rates, but long-term patency remains unknown. Lack of adequate distal outflow appears to be negative prognostic factor when determining long-term patency .
Popliteal Aneurysms
Popliteal artery aneurysms are uncommon, with an estimated incidence of 1 % in the general population [3]. They account for almost 70 % of lower extremity aneurysms [4] and are most commonly true degenerative aneurysms. They can be bilateral in up to 50 % of patients and can be associated with abdominal aortic aneurysm in 30–50 % [4, 5]. They are frequently asymptomatic at time of presentation, with 25–50 % of popliteal artery aneurysms found incidentally. They can also present with symptoms from local compression, thromboembolism or acute limb ischemia, and ischemic rest pain or rarely rupture (less than 2 %). Symptoms from compression usually occur when the aneurysm reaches a size greater than 3 cm and can cause posterior knee fullness, nerve-related pain with paresthesias and foot drop, and congestive venous swelling from associated deep venous thrombosis. Diagnostic modalities are often dependent on initial presentation and will include physical exam findings, duplex ultrasound, and contrast-enhanced CT scans or MRI, which may assist in procedural planning. Vascular ultrasound can be used to evaluate the size of aneurysm, presence of mural thrombus and velocities through the vessel, as well as evidence of leg perfusion with ankle-brachial indices. Contrast angiography alone is limited by showing only luminal flow (when compared to 3D modalities of CT and MRI), but can be useful in demonstrating distal outflow, especially in cases in which there is evidence of distal thromboembolism or when endovascular intervention is considered.
Popliteal artery aneurysms can present as a limb-threatening event, usually caused by thrombosis of the aneurysm with concomitant loss of runoff vessels. From 40 to 50 % of patients present in this manner, an overall have the worst prognosis in respect to limb salvage. If patients present with symptomatic popliteal artery aneurysm or evidence of extremity ischemia, they should undergo urgent repair. In asymptomatic patients with aneurysms greater than 2 cm, elective repair is often recommended. The choice of repair is often dependent on patient-specific issues such as medical comorbidities, functional status, and life expectancy. Elective open repair can be accomplished via two different exposures: medial and posterior. The medial approach can be performed with non-tunneled saphenous vein graft with ligation of the intervening aneurysmal segment of artery. Although the medial approach allows greater ease at greater saphenous vein harvest, it permits the genicular branches to continue to feed the aneurysm sac and can lead to endotension and increased aneurysm size in few cases. The posterior approach with the patient in the prone position allows the surgeon to perform open repair of the aneurysm with ligation of geniculate branches—with complete aneurysm excision, ligation of all branches, and relief of compression symptoms by larger aneurysms. Vein harvest can be more challenging with the patient in the prone position, and the tibial nerve is at risk with a posterior approach.
Endovascular repair is an option for patient with suitable anatomy and adequate outflow vessels and may have a major role in patients with major medical comorbidities. As with any endograft, adequate proximal and distal seal zones are required with freedom from thrombus, excessive calcifications, or tortuosity. CT angiography is usually performed to assist in pre-procedural planning to determine diameter, length, and number of stent grafts necessary for the procedure. Access can be performed percutaneously in patients with normal-sized proximal and distal landing zones , but in patients with arteriomegaly and larger diameter landing zones requiring larger diameter devices, open arterial exposure may be required. When planning endovascular intervention that crosses the knee joint, proper stent graft overlapping can minimize graft slippage and kinking. After repair, patients should remain on dual antiplatelet therapy (clopidogrel and aspirin) with close follow-up with duplex ultrasonography or CT angiogram usually recommended. In patients with acute ischemia from thrombosis or distal embolism, mechanical thrombectomy and catheter-directed thrombolysis are recommended to restore distal runoff and are more likely to be successful with recent thromboembolic events. If there is severe limb ischemia at the time of diagnosis, then endovascular therapy would be contraindicated due to the increased amount of time required to establish distal perfusion, and surgical mechanical thrombectomy would instead be indicated.
Overall 30-day amputation rates are reported as 14.1 % with approximately 20 % of those amputations performed as the primary procedure without attempt at thrombectomy , thrombolysis, or surgical revascularization . Ruptured popliteal aneurysms tend to have higher risk of amputation, with rates as high as 50–75 %. Open operative therapy remains the gold standard for elective repair of popliteal artery aneurysms with long-term limb salvage rates of up to 90 % at 10 years for asymptomatic aneurysms. Success rates decrease significantly with symptomatic popliteal aneurysms, in particular those with acute limb ischemia. Endovascular repair is becoming a more popular option, especially in patients with significant comorbidities, and success rates are dependent on number of patent outflow vessels, with at least two vessels necessary for favorable short-term outcomes. Although patency rates tend to be similar to open repair, there is an increased incidence of interventions required to maintain patency .
External Iliac Artery Endofibrosis
Exercise-induced external iliac endofibrosis is a rare cause of arterial stenosis and is most commonly seen in high-functioning and competitive cyclists. Although it results from repetitive trauma of the external iliac artery, it is unclear why some individuals are affected and others are not. Histologically, the process is different from atherosclerosis, with loosely packed collagen, no calcification, and minimal cellularity causing narrowing of vessel lumen. Patients typically present with intermittent claudication and a sensation of swelling or paresthesias of the proximal lower limb at the time of exercise. Occasionally a bruit can be heard over the pelvic fossa or inguinal region. Diagnosis is made with pre-exercise and post-exercise ankle pressure determinations and duplex ultrasound. Contrast angiography can reveal concentric stenosis and lengthening of the external iliac artery, and intravascular ultrasound can also be used to aid in the diagnosis with measurement of intra-arterial trans-lesional pressure gradients. Conservative therapy should be the initial recommendation, as patients are typically only symptomatic with extreme levels of activity. If patients wish to continue with competitive athletics, there are surgical options available. Surgical treatment can be performed with endofibrosectomy with patch angioplasty or interposition graft replacement of the external iliac artery. Typically the external iliac artery needs to be treated because of the diffuse nature of the disease. Prosthetic bypass should be avoided in these predominantly young, healthy patients. Endovascular treatment has been described with angioplasty or stent placement across the lesion, with early recurrence of symptoms [6, 7].
Cystic Adventitial Disease
Cystic adventitial disease is a rare cause of claudication . Of the 400 described cases, 85 % have been reported in popliteal artery [8]. It is more prevalent in males as compared to females. It is caused by cysts that develop between the media and adventitia of the popliteal artery, which can be single or multiloculated. Theoretical etiologies including involvement of systemic disorders, repetitive trauma to the popliteal artery, and persistent embryonic synovial tract from the knee joint have been reported. Symptoms occur due to compression of the arterial lumen by the cystic collection of mucinous material that causes progressive narrowing of arterial lumen.
Most patients report a waxing and waning course with a sudden onset of calf cramps followed by intermittent claudication that is exacerbated by flexion of the knee. Rarely acute limb ischemia can be a presenting symptom due to compression and thrombosis of an already symptomatic artery. Diagnosis can be made with physical examination with reduced or absent pedal pulses on the affected side and a normal ipsilateral femoral pulses and on the asymptomatic leg. Symptoms are typically unilateral and are present at rest (distinguishing from popliteal artery entrapment which also causes claudication symptoms in young patients). Distal pulses can also be obliterated by sharp flexion of the knee (Ishikawa’s sign), which can also distinguish from popliteal artery entrapment in which pulses disappear with knee extension due to contraction of the gastrocnemius. Traditionally the diagnosis of adventitial cystic disease was confirmed with arteriography with the intramural cyst causing a focal eccentric smooth stenosis (scimitar sign). Duplex ultrasound can also be used to combine arterial imaging with flow abnormalities and may be useful as an initial diagnostic modality. It may demonstrate an avascular, sonolucent arterial stenosis. CTA or MRA can be used to aid in the diagnosis, which can confirm narrowing of arterial lesion, by an intraluminal cystic structure.